The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Open accessAbstract
The chemotherapy drug paclitaxel causes tumor regression and cell death by inducing high rates of chromosome missegregation on multipolar spindles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Taxol stabilizes microtubules in mouse fibroblast cells.
Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,970
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
A mechanism linking extra centrosomes to chromosomal instability
Ganem, N. J., Godinho, S. A., & Pellman, D. (2009) · Nature · doi:10.1038/nature08136 · Cited by 1,422
On the road to cancer: aneuploidy and the mitotic checkpoint
Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1714 · Cited by 1,185
Self-citationMechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
Gascoigne, K. E., & Taylor, S. S. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.002 · Cited by 832 · cited 1×
“Even these genetically identical daughters exhibited differing responses to mitotic arrest (15).”
The Spindle Assembly Checkpoint
Lara-Gonzalez, P., Westhorpe, F. G., & Taylor, S. S. (2012) · Current Biology · doi:10.1016/j.cub.2012.10.006 · Cited by 773
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor
Weaver, B. A. A., Silk, A. D., Montagna, C., Verdier-Pinard, P., & Cleveland, D. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.003 · Cited by 729
Self-citationStuck in Division or Passing through
Rieder, C. L., & Maiato, H. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.002 · Cited by 657
Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice
Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C., Lowe, S. W., & Benezra, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.019 · Cited by 612
Centrosome defects and genetic instability in malignant tumors.
Pihan, G. A., Purohit, A., Wallace, J., Knecht, H., Woda, B. A., Quesenberry, P. J., & Doxsey, S. (1998) · PubMed · Cited by 592
Gianni, L., Kearns, C. M., Giani, A., Capri, G., Viganó, L., Lacatelli, A., Bonadonna, G., & Egorin, M. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.180 · Cited by 553
Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 553
Weaver, B. A. A., & Cleveland, D. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.011 · Cited by 520
Self-citationCole, N. B., Sciaky, N., Marotta, A., Song, J., & Lippincott-Schwartz, J. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.4.631 · Cited by 510
Localization of Mad2 to Kinetochores Depends on Microtubule Attachment, Not Tension
Waters, J. C., Chen, R.-H., Murray, A. W., & Salmon, E. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.5.1181 · Cited by 481
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jackson, J. R., Patrick, D. R., Dar, M. M., & Huang, P. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2049 · Cited by 473
Phase I clinical and pharmacokinetic study of taxol.
Wiernik, P. H., Schwartz, E. L., Strauman, J. J., Dutcher, J. P., Lipton, R. B., & Paietta, E. M. (1987) · PubMed · Cited by 455
Kops, G. J. P. L., Foltz, D. R., & Cleveland, D. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401142101 · Cited by 437
Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas.
Pihan, G. A., Wallace, J., Zhou, Y., & Doxsey, S. (2003) · PubMed · Cited by 429
Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang-Decker, N., & van Deursen, J. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211048 · Cited by 339
Substoichiometric Binding of Taxol Suppresses Microtubule Dynamics
Derry, W. B., Wilson, L., & Jordan, M. A. (1995) · Biochemistry · doi:10.1021/bi00007a014 · Cited by 335
Mitosis is not a key target of microtubule agents in patient tumors
Komlodi-Pasztor, E., Sackett, D., Wilkerson, J., & Fojo, T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.228 · Cited by 314 · cited 2×
“Before thiswork, themajor alternative to the hypothesis that paclitaxel causes anticancer effects as a consequence of mitotic arrest was that it causes cell death in interphase without affecting mitosis (29, 36).”
Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
Janssen, A., Kops, G. J. P. L., & Medema, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904343106 · Cited by 313
Huizing, M. T., Keung, A. C., Rosing, H., van der Kuij, V, ten Bokkel Huinink, W. W., Mandjes, I. M., Dubbelman, A. C., Pinedo, H. M., & Beijnen, J. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2127 · Cited by 308
Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel
Milross, C. G., Mason, K. A., Hunter, N. R., Chung, W.-K., Peters, L. J., & Milas, L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.18.1308 · Cited by 286
Komlodi-Pasztor, E., Sackett, D. L., & Fojo, A. T. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0999 · Cited by 227
Kerr, J. F. R., & Searle, J. (1972) · The Journal of Pathology · doi:10.1002/path.1711070107 · Cited by 227
Michel, L., Diaz-Rodriguez, E., Narayan, G., Hernando, E., Murty, V. V. V. S., & Benezra, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306069101 · Cited by 188
Mitotic drug targets and the development of novel anti-mitotic anticancer drugs
Schmidt, M., & Bastians, H. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.06.003 · Cited by 186
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol
Milas, L., Hunter, N. R., Kurdoglu, B., Mason, K. A., Meyn, R. E., Stephens, L. C., & Peters, L. J. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689448 · Cited by 183
Brito, D. A., Yang, Z., & Rieder, C. L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200805072 · Cited by 174
Orth, J. D., Köhler, R. H., Foijer, F., Sorger, P. K., Weissleder, R., & Mitchison, T. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0412 · Cited by 159
Symmans, W. F., Volm, M. D., Shapiro, R. L., Perkins, A., Kim, A. Y., Demaria, S., Yee, H. T., McMullen, H., Oratz, R., Klein, P., et al. (2000) · PubMed · Cited by 149
Compton, D. A., Yen, T. J., & Cleveland, D. W. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.112.6.1083 · Cited by 111
Ryan, S. D., Britigan, E. M. C., Zasadil, L. M., Witte, K., Audhya, A., Roopra, A., & Weaver, B. A. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201911109 · Cited by 108
Self-citationYang, Z., Kenny, A. E., Brito, D. A., & Rieder, C. L. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200906150 · Cited by 106
Ricke, R. M., Jeganathan, K. B., Malureanu, L. A., Harrison, A. M., & van Deursen, J. M. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201205115 · Cited by 106
Spindle checkpoint function and cellular sensitivity to antimitotic drugs
Yamada, H. Y., & Gorbsky, G. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0319 · Cited by 94
From taxol to taxol®: The changing identities and ownership of an anti-cancer drug
Walsh, V., & Goodman, J. (2002) · Medical Anthropology · doi:10.1080/01459740214074 · Cited by 93
Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer
Chakravarthy, A. B., Kelley, M. C., McLaren, B. K., Truica, C. I., Billheimer, D. D., Mayer, I. A., Grau, A. M., Johnson, D. H., Simpson, J. F., Beauchamp, R. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2304 · Cited by 75
Intravital FRET Imaging of Tumor Cell Viability and Mitosis during Chemotherapy
Janssen, A., Beerling, E., Medema, R. H., & van Rheenen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064029 · Cited by 71
Fine, R. L., Chen, J., Balmaceda, C. M., Bruce, J. N., Huang, M., Desai, M., Sisti, M. B., McKhann, G. M., Goodman, R. R., Bertino, J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2356 · Cited by 67
Lera, R. F., & Burkard, M. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.412544 · Cited by 58
Self-citationMad2 binding by phosphorylated kinetochores links error detection and checkpoint action in mitosis
Waters, J. C., Chen, R., Murray, A. W., Gorbsky, G. J., Salmon, E. D., & Nicklas, R. B. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80287-5 · Cited by 56
Analysis of spindle microtubule organization in untreated and taxol‐treated PtK1 cells.
Snyder, J. A., & Mullins, J. M. (1993) · Cell Biology International · doi:10.1006/cbir.1993.1040 · Cited by 20
Tales of How Great Drugs Were Brought Down by a Flawed Rationale—Letter
Wissing, M. D., Carducci, M. A., Gelderblom, H. A. J., & van Diest, P. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2695 · Cited by 6
Tales of How Great Drugs Were Brought Down by a Flawed Rationale—Letter
Tunquist, B. J., Wood, K. W., & Walker, D. H. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1041 · Cited by 5
Cited by
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
Self-citationMatthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00404-3 · Cited by 1,506
Structural and Chemical Biology of Terpenoid Cyclases
Christianson, D. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00287 · Cited by 1,223
Patient-derived xenografts undergo mouse-specific tumor evolution
Ben-David, U., Ha, G., Tseng, Y.-Y., Greenwald, N. F., Oh, C., Shih, J., McFarland, J. M., Wong, B., Boehm, J. S., Beroukhim, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3967 · Cited by 716
Metadata
- Authors
- Zasadil, L. M., Andersen, K. A., Yeum, D., Rocque, G. B., Wilke, L. G., Tevaarwerk, A. J., Raines, R. T., Burkard, M. E., & Weaver, B. A.
- Venue
- Science Translational Medicine
- Published
- 2014-03-26
- Volume
- 6
- Issue
- 229
- Pages
- 229ra43-229ra43
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2071359790
- Cited by
- 402
- References
- 52
- FWCI
- 14.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.